Dietmar identified two to five novel potential tumor-suppressor or antagonist gene candidates in ovarian cancer from chromosome band 8p22 (N33 and EFA6R, with effects on survival, and potentially FLJ32642, MTSG1, and PCM1), which are promising candidates for further functional analysis of ovarian cancer [40]. The gene discussed is PCM1; the disease is neoplasm.